Nov 2023: Nivolumab (Opdivo, Bristol-Myers Squibb Kambani) yakapihwa mvumo neFood and Drug Administration senzira yekurapa yeStage IIB/C melanoma muvarwere vane makore gumi nemaviri zvichikwira vanga vapedza.
Kubvumbi 2022: Iyo US Chikafu neDrug Administration (FDA) yakabvumidza Opdualag (nivolumab uye relatlimab-rmbw), mutsva, wekutanga-mu-kirasi yakatarwa-dose musanganiswa we nivolumab uye relatlimab inopihwa seimwe intravenous infusion, f.
Kurume 2022: Tebentafusp-tebn (Kimmtrak, Immunocore Limited), bispecific gp100 peptide-HLA-inotungamirwa CD3 T cell engager, akapihwa rezinesi neFood and Drug Administration yeHLA-A*02:01-positive varwere vakuru vane unresectab. .
Nyamavhuvhu 2021: Melphalan flufenamide (Pepaxto, Oncopeptides AB) yakabatana ne dexamethasone yakapihwa mvumo yekukurumidza neKudya neDrug Administration kwevakuru varwere vane yakadzokororwa kana kusagadzikana yakawanda myel ..
Musi waKukadzi 15, 2019, pembrolizumab (KEYTRUDA, Merck) yakabvumidzwa neFood and Drug Administration yekurapa adjuvant yevarwere vane melanoma nekubatanidzwa kwemalymph node (s) mushure mekuvhiyiwa kwakazara. Kubvumirwa..
Kunze kwekukurumidza uye kusingaperi kurasikirwa nekurema uye mamwe mabhenefiti ehutano, kuvhiyiwa bariatric iko zvino kwakabatana ne61% yakaderedzwa njodzi yemaronda anonyanyisa melanoma, inova kenza yeganda inouraya zvakanyanya inosanganisirwa neyakawandisa s ..